Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tarek Mohamed Mostafa"'
Autor:
Eman El-Khateeb PhD, Sahar Mohamed El-Haggar PhD, Osama El-Razaky MD, Mohamed Ramadan El-Shanshory MD, Tarek Mohamed Mostafa PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 27 (2022)
Background: Pulmonary hypertension (PHT) is common in β-thalassemia patients due to hemolysis, iron overload and diminished nitric oxide (NO) levels. Biochemical markers can help to understand the pathophysiology and to introduce new therapies for t
Externí odkaz:
https://doaj.org/article/4700590eea4f44beb9492915b38fae4c
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 76, Iss 7, Pp 452-458
ABSTRACT The purpose of this study was to determine the effect of lamotrigine (LTG) and levetiracetam (LEV) as mono- and polytherapy on biochemical markers of bone turnover and bone mineral density in Egyptian adult patients with epilepsy. Methods Fo
Externí odkaz:
https://doaj.org/article/cbcc7b941f9d49018e2a837a360fe0eb
Autor:
Aya Ahmed El-attar, Osama Mohamed Ibrahim, Suzan Ahmed Alhassanin, Enas Said Essa, Tarek Mohamed Mostafa
Publikováno v:
European Journal of Clinical Pharmacology. 79:299-309
Introduction Metformin may provide a therapeutic benefit in different types of malignancy. Purpose We aimed at evaluating the effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of br
Publikováno v:
Journal of Applied Biomedicine. 19:62-72
This study aimed at evaluating the role played by insulin resistance, lipid metabolism disorder, oxidative stress, resistin, vaspin, Interleukin-18 and asymmetric dimethyl arginine as a marker for endothelial dysfunction in the pathogenesis of preecl
Autor:
aya ahmed elattar, Osama Mohamed Ibrahim, Suzan Ahmed Alhassanin, Enas Said Essa, Tarek Mohamed Mostafa
Introduction: Metformin may provide therapeutic benefits to patients with various types of malignancy. Through its insulin-sensitizing effect, metformin can also reduce weight in non-diabetic populations.Purpose: Our research aimed at evaluating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3cb8c07e5b79940471900b277f327ca
https://doi.org/10.21203/rs.3.rs-1365471/v1
https://doi.org/10.21203/rs.3.rs-1365471/v1
Autor:
Tarek Mohamed, Mostafa, Sahar Kamal, Hegazy, Salwa El-Morsy Abd, El-Ghany, Fedaa Abd El-Monem, Kotkata
Publikováno v:
European journal of clinical pharmacology. 77(12)
Investigating the efficacy and safety of rupatadine (RUP) versus montelukast (MON) as adjuvant therapy for patients with rheumatoid arthritis (RA).From December 2018 to December 2019, 75 patients with active RA were enrolled in this randomized double